Junko Haraga

Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy

Junko Haraga, Keiichiro Nakamura, Chiaki Omichi et al. · Molecular and Clinical Oncology · 2016 · 79 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability

Tomoko Haruma, Takeshi Nagasaka, Keiichiro Nakamura et al. · PLoS ONE · 2018 · 51 citations · Full text

Medicine, Genetics, Oncology +17

Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy

Keiichiro Nakamura, Takeshi Nishida, Tomoko Haruma et al. · Molecular and Clinical Oncology · 2015 · 45 citations · Full text

Medicine, Oncology, Cancer Immunology +14

Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy

Takanori Kiyotoki, Keiichiro Nakamura, Junko Haraga et al. · International Journal of Gynecological Cancer · 2017 · 42 citations

Medicine, Oncology, Radiation Oncology +17

Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles

Yoshiko Mori, Akihiro Nyuya, Kazuya Yasui et al. · Oncotarget · 2018 · 41 citations · Full text

Medicine, Oncology, Surgery +17